The Silent Epidemics Hiding in Plain Sight: What Latest Global Research Means for India’s Children

By Dr. Vikar Saiyad | Public Health Strategist & Researcher | May 2026

Every year, India’s health system faces a paradox: we celebrate reductions in child mortality rates, yet the absolute burden of preventable deaths — from pneumonia, meningitis, and now a newly recognised metabolic threat — remains unacceptably high. Three landmark studies published in 2025 and 2026, all indexed in PubMed and drawing on the most comprehensive global datasets ever assembled, demand our urgent attention. They don’t just describe the problem — they show us where India must act now.

1. Pneumonia: We Are Not There Yet

The Global Burden of Disease Study 2023, published in The Lancet Infectious Diseases (December 2025), delivers a sobering headline: lower respiratory infections (LRIs) remain the world’s leading infectious cause of death. In 2023 alone, LRIs caused an estimated 2.50 million deaths globally and over 98.7 million disability-adjusted life years (DALYs).

Children under five and adults over 70 bear the heaviest burden. The good news? Under-five LRI mortality dropped by 33.4% since 2010 globally — a hard-won gain driven by immunisation scale-up and improved facility care. The sobering news? The global under-five mortality rate from pneumonia in 2023 still stood at 94.8 per 100,000 person-years — well above the WHO’s Global Action Plan for Prevention and Control of Pneumonia and Diarrhoea (GAPPD) target of fewer than 60 deaths per 100,000.

Among the key causative pathogens, Streptococcus pneumoniae continues to account for the single largest share of LRI deaths globally — followed by Staphylococcus aureus and Klebsiella pneumoniae. Critically, the study modelled 11 newly tracked pathogens — including non-tuberculous mycobacteria and Aspergillus species — which together contributed approximately 22% of LRI deaths. These are pathogens our existing surveillance systems are often blind to.

What This Means for India

India accounts for a significant share of the global pneumonia burden. While we have expanded PCV (pneumococcal conjugate vaccine) coverage under the Universal Immunisation Programme, several critical gaps persist:

• Cold chain failures in peripheral areas compromise vaccine potency
• Delayed care-seeking behaviour, particularly in tribal, remote, and urban-poor settings, means children arrive at facilities with advanced disease
• Antibiotic resistance — particularly Klebsiella and Staph aureus — is rising in Indian NICUs and paediatric wards
• Household air pollution — still the norm for millions of rural households — dramatically increases LRI risk

District health teams need to track pneumonia-specific under-five mortality rates locally, not just aggregate child mortality. The GAPPD target is a district-level accountability tool as much as a national aspiration.

Action Point: Every district should review its pneumonia case fatality rate at CHC and DH level. If CFR >5% in under-five admissions, it signals a system problem — not just a disease problem.

Source: Global Burden of Disease Study 2023 – Lower Respiratory Infections. The Lancet Infectious Diseases, Dec 2025. DOI: 10.1016/S1473-3099(25)00689-9

2. Meningitis: The Forgotten Neurological Catastrophe

A second landmark GBD 2023 analysis, published in The Lancet Neurology (2026), presents the most comprehensive meningitis burden estimates to date — tracking 17 causative pathogens across the globe. The findings are alarming: in 2023, meningitis caused approximately 259,000 deaths and 2.54 million incident cases worldwide. Children under five accounted for over a third of all deaths.

Despite significant progress since 1990, the world is not on track to meet the WHO’s 2030 meningitis targets. Streptococcus pneumoniae, Neisseria meningitidis, enteroviruses, and emerging pathogens like drug-resistant fungi are now collectively reshaping the meningitis landscape. The four WHO-priority preventable pathogens alone caused nearly 98,700 deaths and 594,000 cases in 2023.

Most crucially for India: the study identified low birthweight, preterm birth, and household air pollution as the top three modifiable risk factors for meningitis mortality — all of which disproportionately burden India’s newborn population.

Why This Matters for Neonatal Health in India

Neonatal meningitis — occurring in the first 28 days of life — is notoriously difficult to diagnose in resource-constrained settings. Symptoms overlap with sepsis and may be absent or subtle. Many district hospitals lack the capacity for lumbar puncture or CSF analysis. This study is a reminder that:

• Reducing low birthweight and preterm birth is not just a survival statistic — it’s a neuroprotective intervention
• Newborn care corners and SNCU protocols must include meningitis in the sepsis management pathway
• Group B Streptococcus (GBS) — a major cause of neonatal meningitis — should be on the radar for maternal screening programmes, especially in high-risk deliveries

Action Point: Facilities implementing the UHRP (Universal Health Risk Profiling) for pregnant women should flag LBW and preterm births for targeted newborn surveillance. Meningitis must be explicitly included in neonatal death audit tools.

Source: GBD 2023 – Meningitis. The Lancet Neurology, Vol. 25, Issue 5, pp. 451–468. DOI: 10.1016/S1474-4422(26)00101-8

3. Normal Weight, Abnormal Metabolism: The Hidden Threat in Indian Children

The third study — arguably the most counterintuitive — comes from researchers at St. John’s Research Institute, Bengaluru, and Manipal Academy of Higher Education. Published in BMJ Paediatrics Open (April 2026), this systematic review reveals a critical blind spot in how we assess child health: Metabolically Obese Normal Weight (MONW) phenotype.

Children with MONW have a normal Body Mass Index (BMI) — so they pass standard screening — but carry hidden metabolic risks: elevated visceral fat, insulin resistance, dyslipidaemia, hypertension, and chronic low-grade inflammation. The review, covering studies from 2000 to 2026, found the prevalence of MONW in children ranging from 10.6% to 56.2% depending on the population and diagnostic criteria used. That is not a marginal finding — that is a public health emergency hiding behind a normal growth chart.

Key early-life determinants identified include extreme birth weights (both high and low), rapid infant weight gain, adverse maternal metabolic status during pregnancy, unhealthy dietary patterns, and sedentary behaviour. The authors explicitly warn that reliance on BMI alone may delay identification of vulnerable children, allowing cardiometabolic disease to take root silently across childhood and adolescence.

The India-Specific Crisis

India is already navigating a dual burden of undernutrition and overnutrition. But MONW adds a third, invisible layer. Indian children are genetically predisposed to higher visceral adiposity at lower BMIs — a pattern well-documented in South Asian populations. This means:

• A child in Madhya Pradesh with a normal MUAC and BMI-for-age may already be on a path to type-2 diabetes and cardiovascular disease
• Growth monitoring tools used by ANMs and AWWs — designed to catch undernutrition — will systematically miss this risk
• School health programmes that only screen height and weight are providing false reassurance to families of metabolically compromised children

The study calls for harmonised operational definitions of MONW and robust longitudinal studies — but the policy message is already clear: we need to move beyond BMI in child health surveillance.

Action Point: Integrate waist circumference and fasting glucose screening into the school health programme, particularly in urban and peri-urban settings. Train ANMs and AWWs to flag children with rapid weight gain in infancy, regardless of current weight status.

Source: Farooqui M, Selvam S, Kuriyan R. Metabolically obese normal weight phenotype in children and adolescents aged 3 to 18 years: a systematic review. BMJ Paediatrics Open. April 2026. DOI: 10.1136/bmjpo-2025-004412

The Common Thread: System Readiness and Early Detection

These three studies — on pneumonia, meningitis, and MONW — seem disparate at first glance. But they share a unifying message for India’s public health system:

1. Surveillance is broken — we are counting deaths, not causes; measuring weight, not metabolism; diagnosing sepsis, not meningitis
2. Prevention requires upstream action — low birthweight, household air pollution, and poor maternal nutrition are the common roots of multiple disease burdens
3. Accountability must go beyond targets — district-level CFR tracking, facility audit tools, and frontline capacity development are not optional extras; they are the machinery of survival

India has the political will, the programme architecture (NHM, RBSK, SAANS, LaQshya), and the data infrastructure to respond. What we need now is the implementation rigour to match the research evidence.

References (PubMed)

All articles cited in this post are retrieved from PubMed, the US National Library of Medicine’s biomedical literature database.

1. GBD 2023 Lower Respiratory Infections Collaborators. The Lancet Infectious Diseases. 2025 Dec 15;26(4):343–361. https://doi.org/10.1016/S1473-3099(25)00689-9 [PMID: 41412141]
2. GBD 2023 Meningitis Collaborators. The Lancet Neurology. 2026;25(5):451–468. https://doi.org/10.1016/S1474-4422(26)00101-8 [PMID: 41911930]
3. Farooqui M, Selvam S, Kuriyan R. Metabolically obese normal weight phenotype in children and adolescents aged 3 to 18 years: a systematic review. BMJ Paediatrics Open. 2026 Apr 24;10(1). https://doi.org/10.1136/bmjpo-2025-004412 [PMID: 42031425]

PublicHealthIndia.in translates global evidence into district-level action. If you found this post useful, share it with your team, cite it in your next program review, or use it to raise a question with your health department. Evidence without advocacy is just data.